Register

SmallMolecules.com > Supplier: caymanchemical

Cayman Chemical

Our mission is to help make research possible by supplying scientists worldwide with the basic research tools necessary for advancing human and animal health. Our utmost commitment to healthcare researchers is to offer the highest quality products with an affordable pricing policy.

Company Website

Product Listing

ZLN005 (hydrochloride) 50 mg | ≥98%

Cayman Chemical

A small molecule activator of PGC-1a expression

More Information Supplier Page

ZLN005 (hydrochloride) 25 mg | ≥98%

Cayman Chemical

A small molecule activator of PGC-1a expression

More Information Supplier Page

ZLN005 (hydrochloride) 10 mg | ≥98%

Cayman Chemical

A small molecule activator of PGC-1a expression

More Information Supplier Page

ZLN005 (hydrochloride) 5 mg | ≥98%

Cayman Chemical

A small molecule activator of PGC-1a expression

More Information Supplier Page

ZLN024 50 mg | ≥98%

Cayman Chemical

An allosteric activator of AMPK

More Information Supplier Page

ZLN024 25 mg | ≥98%

Cayman Chemical

An allosteric activator of AMPK

More Information Supplier Page

ZLN024 10 mg | ≥98%

Cayman Chemical

An allosteric activator of AMPK

More Information Supplier Page

ZLN024 5 mg | ≥98%

Cayman Chemical

An allosteric activator of AMPK

More Information Supplier Page

ZLY032 50 mg | ≥98%

Cayman Chemical

A dual FFAR1 and PPARd agonist

More Information Supplier Page

ZLY032 25 mg | ≥98%

Cayman Chemical

A dual FFAR1 and PPARd agonist

More Information Supplier Page

ZLY032 10 mg | ≥98%

Cayman Chemical

A dual FFAR1 and PPARd agonist

More Information Supplier Page

ZLY032 5 mg | ≥98%

Cayman Chemical

A dual FFAR1 and PPARd agonist

More Information Supplier Page

ZLY28 1 mg | ≥90%

Cayman Chemical

An FXR agonist and inhibitor of FABP1

More Information Supplier Page

ZLY28 5 mg | ≥90%

Cayman Chemical

An FXR agonist and inhibitor of FABP1

More Information Supplier Page

ZM 226600 10 mg | ≥98%

Cayman Chemical

An activator of KATP channels

More Information Supplier Page

ZM 226600 100 mg | ≥98%

Cayman Chemical

An activator of KATP channels

More Information Supplier Page

ZM 226600 5 mg | ≥98%

Cayman Chemical

An activator of KATP channels

More Information Supplier Page

ZM 226600 50 mg | ≥98%

Cayman Chemical

An activator of KATP channels

More Information Supplier Page

ZM 241385 25 mg | ≥98%

Cayman Chemical

An A2A adenosine receptor antagonist

More Information Supplier Page

ZM 241385 10 mg | ≥98%

Cayman Chemical

An A2A adenosine receptor antagonist

More Information Supplier Page

ZM 241385 5 mg | ≥98%

Cayman Chemical

An A2A adenosine receptor antagonist

More Information Supplier Page

ZM 241385 1 mg | ≥98%

Cayman Chemical

An A2A adenosine receptor antagonist

More Information Supplier Page

ZM 306416 10 mg | ≥98%

Cayman Chemical

A VEGF receptor kinase inhibitor

More Information Supplier Page

ZM 306416 5 mg | ≥98%

Cayman Chemical

A VEGF receptor kinase inhibitor

More Information Supplier Page

ZM 306416 1 mg | ≥98%

Cayman Chemical

A VEGF receptor kinase inhibitor

More Information Supplier Page

ZM 323881 (hydrochloride) 25 mg | ≥98%

Cayman Chemical

A potent and selective VEGFR2 inhibitor

More Information Supplier Page

ZM 323881 (hydrochloride) 10 mg | ≥98%

Cayman Chemical

A potent and selective VEGFR2 inhibitor

More Information Supplier Page

ZM 323881 (hydrochloride) 5 mg | ≥98%

Cayman Chemical

A potent and selective VEGFR2 inhibitor

More Information Supplier Page

ZM 323881 (hydrochloride) 1 mg | ≥98%

Cayman Chemical

A potent and selective VEGFR2 inhibitor

More Information Supplier Page

ZM 336372 25 mg | ≥98%

Cayman Chemical

An activator of the Raf-1 signalling pathway

More Information Supplier Page

ZM 336372 10 mg | ≥98%

Cayman Chemical

An activator of the Raf-1 signalling pathway

More Information Supplier Page

ZM 336372 5 mg | ≥98%

Cayman Chemical

An activator of the Raf-1 signalling pathway

More Information Supplier Page

ZM 336372 1 mg | ≥98%

Cayman Chemical

An activator of the Raf-1 signalling pathway

More Information Supplier Page

ZM 39923 (hydrochloride) 10 mg | ≥98%

Cayman Chemical

A potent inhibitor of JAK3

More Information Supplier Page

ZM 39923 (hydrochloride) 5 mg | ≥98%

Cayman Chemical

A potent inhibitor of JAK3

More Information Supplier Page

ZM 39923 (hydrochloride) 1 mg | ≥98%

Cayman Chemical

A potent inhibitor of JAK3

More Information Supplier Page

ZM 447439 50 mg | ≥98%

Cayman Chemical

Selective inhibitor of Aurora B kinase

More Information Supplier Page

ZM 447439 10 mg | ≥98%

Cayman Chemical

Selective inhibitor of Aurora B kinase

More Information Supplier Page

ZM 447439 5 mg | ≥98%

Cayman Chemical

Selective inhibitor of Aurora B kinase

More Information Supplier Page

ZM 449829 50 mg | ≥95%

Cayman Chemical

An inhibitor of JAK3

More Information Supplier Page

ZM 449829 25 mg | ≥95%

Cayman Chemical

An inhibitor of JAK3

More Information Supplier Page

ZM 449829 10 mg | ≥95%

Cayman Chemical

An inhibitor of JAK3

More Information Supplier Page

ZM 449829 5 mg | ≥95%

Cayman Chemical

An inhibitor of JAK3

More Information Supplier Page

ZM 522 100 mg | ≥98%

Cayman Chemical

An inhibitor of ecto-5’-nucleotidase

More Information Supplier Page

ZM 522 50 mg | ≥98%

Cayman Chemical

An inhibitor of ecto-5’-nucleotidase

More Information Supplier Page

ZM 522 25 mg | ≥98%

Cayman Chemical

An inhibitor of ecto-5’-nucleotidase

More Information Supplier Page

Zofenopril (calcium salt) 25 mg | ≥98%

Cayman Chemical

A prodrug form of zofenoprilat

More Information Supplier Page

Zofenopril (calcium salt) 10 mg | ≥98%

Cayman Chemical

A prodrug form of zofenoprilat

More Information Supplier Page

Zofenopril (calcium salt) 5 mg | ≥98%

Cayman Chemical

A prodrug form of zofenoprilat

More Information Supplier Page

Zofenoprilat 5 mg | ≥95%

Cayman Chemical

An ACE inhibitor and active metabolite of zofenopril

More Information Supplier Page